50 results about "Molecular pathway" patented technology

The present invention provides tools and methods for the systematic analysis of genetic interactions, including higher order interactions. The present invention provides tools and methods for combinatorial probing of cellular circuits, for dissecting cellular circuitry, for delineating molecular pathways, and / or for identifying relevant targets for therapeutics development.

The present invention relates to the discovery of a novel molecular pathway involved in long-term hyperexcitability of sensory neurons, which, in higher animals, is associated with persistent pain. It is based on the discovery that, following injury to an axon of a neuron, an increase in nitric oxide synthase activity results in increased nitric oxide production, which, in turn, activates guanylyl cyclase, thereby increasing levels of cGMP. Increased cGMP results in activation of protein kinase G (“PKG”), which then is retrogradely transported along the axon to the neuron cell body, where it phosphorylates MAPKerk.

The present invention provides methods for identifying genes and pathways involved in plasticity. The invention applies some of these methods to identify genes that are differentially regulated in at least a portion of the nervous system of an individual subjected to conditions known to result in altered nervous system plasticity, i.e., dark rearing (DR) or monocular deprivation (MD). The genes are targets for pharmacological agents that modify plasticity. The invention also identifies biological pathways that are enriched in genes that are differentially regulated under conditions known to result in altered nervous system plasticity. The present invention further provides methods and compositions for modifying plasticity in the nervous system of a subject. The invention includes a method for modifying plasticity in the nervous system of a subject comprising administering a plasticity-modifying agent to the subject, wherein the plasticity-enhancing agent modulates a gene or pathway that is differentially regulated in developmental conditions that alter nervous system plasticity (e.g., DR or MD). The methods and compositions may be administered to a subject suffering from damage to the nervous system or from a neuropsychiatric disorder in order to enhance recovery, reorganization, or function of the nervous system. The methods optionally include administering a proteolysis-enhancing agent to the subject.

The invention belongs to the technical field of molecular biology, and specifically relates to the application of WDR1 gene in the preparation of products for the treatment and detection of non-small cell lung cancer. The present invention discloses for the first time that the human WDR1 gene is a valuable biomarker in the process of tumor occurrence and development, and is expected to become a potential target for the treatment strategy of non-small cell lung cancer. The human WDR1 gene is used in the preparation of non-small cell lung cancer screening and detection products And non-small cell lung cancer treatment prognosis detection products have certain application value, provide certain clues and new perspectives for the early detection, diagnosis and prognosis of NSCLC, help to develop targeted drugs for NSCLC treatment, and improve the treatment status of NSCLC , has potential and good application prospects in the fields of tumor detection, diagnosis and treatment; the invention provides new theoretical basis and direction for clarifying the potential molecular pathway and mechanism of NSCLC occurrence and development.